News

The investment will fuel the international expansion of Cytely's AI-driven microscopy platform, which automates cell analysis and dramatically speeds up biomedical research. We're thrilled to lead this round and support the mission to make smart, data‑centric microscopy accessible to every lab, said Louise Lachmann, Partner at Ugly Duckling Ventures. Cytely transforms any microscope into a real-time measurement instrument, closing the loop from acquisition to decision on an experiment-day timescale rather than a grant cycle," says Philip Nordenfelt, Cytely co-founder & CEO With the new funding, Cytely will further develop its AI platform to make it even more intuitive, enable collaboration between researchers, and expand operations in the U.S. and Asia. The long-term goal is to build a global discovery system that helps scientists make breakthroughs faster and eventually predict outcomes and autonomously drive parts of the research process."